Draquinolol

Chemical compound
  • none
Identifiers
  • 3-(4-{2-Hydroxy-3-[(2-methyl-2-propanyl)amino]propoxy}phenyl)-7-methoxy-2-methyl-1(2H)-isoquinolinone
CAS Number
  • 67793-71-9
PubChem CID
  • 10070156
ChemSpider
  • 8245696
UNII
  • K3B3L3Q0GV
Chemical and physical dataFormulaC24H30N2O4Molar mass410.514 g·mol−13D model (JSmol)
  • Interactive image
  • CC(C)(C)NCC(COC1=CC=C(C=C1)C2=CC3=C(C=C(C=C3)OC)C(=O)N2C)O
InChI
  • InChI=1S/C24H30N2O4/c1-24(2,3)25-14-18(27)15-30-19-9-6-16(7-10-19)22-12-17-8-11-20(29-5)13-21(17)23(28)26(22)4/h6-13,18,25,27H,14-15H2,1-5H3
  • Key:MZELTXWHFDTAOO-UHFFFAOYSA-N

Draquinolol is a beta blocker with selectivity for the β1 receptor.[1]

References

  1. ^ Morton IK, Hall JM (1999). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer. p. 106.


  • v
  • t
  • e
Adrenergic receptor modulators
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
  • See also: Receptor/signaling modulators
  • Dopaminergics
  • Serotonergics
  • Monoamine reuptake inhibitors
  • Monoamine releasing agents
  • Monoamine metabolism modulators
  • Monoamine neurotoxins


Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e